Perspective Therapeutics, Inc. — Director's Dealing 2024

Mar 8, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2024-03-06

Reporting Person: Lantheus Alpha Therapy, LLC (N/A)
Reporting Person: Lantheus Holdings, Inc. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-06	Common Stock	P	60431039	$0.95	Acquired	116773394	Direct

Footnotes

F1: Represents securities directly held by Lantheus Alpha Therapy, LLC, ("Lantheus"), a wholly owned direct subsidiary of Lantheus Holdings, Inc. ("Lantheus Holdings"). Under SEC rules and regulations, Lantheus Holdings may be deemed to have indirect beneficial ownership of the shares held by Lantheus, which has direct beneficial ownership.